The objective of this study was to describe the intraocular pressure-lowering efficacy of
AL-3789 over a 24-hour period in patients with open-angle glaucoma compared to an untreated
control. Patients received one treatment of AL-3789. Twenty-eight days after treatment, IOP
was measured every 4 hours, beginning at 8 AM for 24 hours.